Titre : | Xylazine - Medical and public health imperatives (2023) |
Auteurs : | R. GUPTA ; D. R. HOLTGRAVE ; M. A. ASHBURN |
Type de document : | Article : Périodique |
Dans : | New England Journal of Medicine (Vol.388, n°24, June 15, 2023) |
Article en page(s) : | 2209-2212 |
Langues: | Anglais |
Discipline : | MAR (Marchés / Markets) |
Mots-clés : |
Thésaurus géographique ETATS-UNISThésaurus mots-clés ANTALGIQUES ; FENTANYL ; ADULTERANT ; PHENOMENE EMERGENT ; PRODUIT ILLICITE ; MESUSAGE ; SURDOSE ; EVOLUTION ; EFFET SECONDAIRE ; PEAU ; NECROSE |
Résumé : | Use of xylazine, most often in combination with other drugs such as fentanyl, is a rapidly growing health threat. People being harmed by this drug deserve rapid, comprehensive, and high-quality care. |
Domaine : | Autres substances / Other substances |
Refs biblio. : | 5 |
Affiliation : |
White House Office of National Drug Control Policy, Washington, DC, USA Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, USA |
Lien : | https://doi.org/10.1056/NEJMp2303120 |
